[70] Additionally, increased plasma erythropoietin and reticulocytosis indicate hypoxia, especially in the medulla of the kidney, as a result of SGLT2 inhibition
PMID 26900906 Feb 2016 low glp-1 producers study and Jessica Browns Video on it here 10 Solid Reasons Why Yo-Yo Dieting is Bad for You , Healthline, May 2017 Glucagon-like peptide-1 agonist safety and efficacy in a multiple sclerosis cohort , PMID: 39693702, Dec 2024 Glucagonlike peptide1 receptor agonists in multiple sclerosis: therapeutic promise, challenges, and future directions , PMID: 41196232 Brigham-Led Study Finds Weight Loss Drug Semaglutide Reduced COVID-19 Related Deaths During the Pandemic , Mass General Brigham, Sept 2024 Semaglutide Reduces Cardiovascular and COVID Death , Mass General Brigham, Dec 2024 RECOVER-TLC Zepbound Gets New Test: Long Covid Treatment Trial Begins , Foundations for the National Institutes of Health Semaglutide Reduces COVID-19 Related Deaths in Patients with Obesity and CVD , American College of Cardiology, Aug 2024 Yes, weight-loss drugs work but nutrition needs attention , Hunter Medical Research Institute, Feb 2026 GLP-1 Receptor Agonists and Chronic Migraine: A Real-World Cohort Study of Healthcare Utilization and Preventive Escalation , AAN, Mar 2026 More Good News for GLP-1 Agonists and Cancer Risk , Med Page Today, Feb 2026 Weight Cycling and Its Cardiometabolic Impact , PMID: 31089525, Dec 2017 The Thyroid Twist: How GLP-1 Agonists Are Influencing Autoimmune Thyroid Care , PMID: 41479489, Nov 2025 Glucagon-like peptide and its receptor agonists for the treatment of rheumatic diseases , PMID: 41523775, Sep 2025 The potential role of GLP-1 receptor agonists in the management of psoriatic disease: a scoping review , PMID: 41266905, Nov 2025 Roles of glucagon-like peptide 1 receptor agonists in immune cell biology and autoimmune/ autoinflammatory diseases , PMID: 41074143 The immunomodulatory effects of GLP-1 receptor agonists in neurogenerative diseases and ischemic stroke treatment , PMID: 40134421 GLP-1 Receptor Agonists Show Promise in Rheumatic Disease , MedCentral, Nov 2025 Evaluating the causal effect of using glucagon-like peptide-1 receptor agonists on the risk of autoimmune diseases , Science Direct, Jan 2025 The Potential of GLP-1 in the Treatment of Autoimmune Diseases: A Review of Mechanisms and Clinical Data, International Journal of Innovative Technologies in Social Science , Vol 3 No 3 2025 Study Flags Autoimmune Concerns with GLP-1 Use , American Medical Journal, Jun 2025 Association between autoimmune diseases and glucagon-like peptide-1 receptor agonists: A real-world evidence study , Science Direct, July 2025 GLP-1RA Therapy Linked to Lower Incidence of Rheumatic Diseases , Endocrinology Advisor, Oct 2025 The immunomodulatory effects of GLP-1 receptor agonists in neurogenerative diseases and ischemic stroke treatment , Frontiers, Mar 2025 Glucagon-like peptide 1 receptor is a T cell-negative costimulatory molecule , Science Direct, Jun 2024 Obesity-Mediated Immune Modulation: One Step Forward , (Th)2 Steps Back, Frontiers, Jun 2022 GLP-1R agonist therapy and vaccine response , Science Direct, Aug 2024 Using GLP-1 Agonists with Biologics in Autoimmune Conditions, Chicago Arthritis and Regenerative Medicine , Jan 2025 Total estimated usual nutrient intake and nutrient status biomarkers in women of childbearing age and women of menopausal age , ScienceDirect, Apr 2021 Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications , PMID: 38288136, Jan 2024 New Research at ACR Convergence 2025 Highlights Potential of GLP-1 Therapies in Rheumatic Disease Management , American College of Rheumatology, Oct 2025 GLP-1 receptor agonists cut risk of death in inflammatory disease patients , Clinical Trials Arena, Aug 2024 GLP-1 Levels Linked to Brain Inflammation in Autoimmune Disorder , Managed Healthcare, Sept 2025 Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomized Controlled Trials , Frontiers, Jul 2022 Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons , PMID: 40924351, Sept 2025 The anti-inflammatory and immunological properties of GLP-1 Receptor Agonists , Science Direct, Aug 2022 Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent , Frontiers, May 2023 Antiinflammatory actions of glucagon-like peptide-1based therapies beyond metabolic benefits , The Journal of Clinical Investigation, Nov 2025 Five things to know about GLP-1s and addiction, Stanford Medicine, Apr 2025 The role of glucagonlike peptide 1 (GLP1) in addictive disorders , PMID: 34532853, Feb 2022 A Systematic Review on GLP-1 Receptor Agonists in Reproductive Health: Integrating IVF Data, Ovarian Physiology and Molecular Mechanisms , PMID: 41596408, Jan 2026 The dual impact of GLP-1 receptor agonists on metabolic and reproductive health in polycystic ovary syndrome: insights from human and animal trial , PMID: 41069706, Oct 2025 Relevance of GLP-1 Agonists for Infertility Practice, Science Direct, Nov 2024 FDA Intends to Take Action Against Non-FDA-Approved GLP-1 Drugs , FDA, Feb 2026 Is It Bad to Lose Weight Too Quickly , Healthline, Sept 2025 Thank you to Jessica Brown, author of Beyond the Shot , for her help with this research and joining me for this incredibly vulnerable and detailed podcast
Skipping caffeine and alcohol is beneficial
The Q-angle is the angle formed by a line drawn from the anterior superior iliac spine to the center of the patella and another line from the center of the patella to the tibial tubercle
At Youthbar, your plan is thoughtful, precise, and curated to bring you back to yourself, sustainably
